Skip to main content
. Author manuscript; available in PMC: 2010 Apr 30.
Published in final edited form as: Mol Cell Proteomics. 2007 Oct 19;7(1):35–45. doi: 10.1074/mcp.M700353-MCP200

TABLE 4.

Drugs used in this study

Drug Conc. Mechanism Reference Rsp5-dependent sensitivities
HU 0.2M ribonucleotide reductase dependent inhibition of DNA synthesis Mulder K W, et al., 2005 Yes
MMS 0.03% DNA-damaging alkylating agents Lundin C, et al., 2005 No
CPT 40μg/ml DNA-damaging topoisomerase-I inhibition Wang LF, et al., 1997 No